|
1. FDA grants priority review to breast cancer drug Full story
2. FDA delays approval of AstraZeneca's injectable lupus drug Full story
3. Margins, power brokers & site-of-care shifts — Get experts' take on 2026's big trends here.
4. Eli Lilly plans $3.5B injectable manufacturing site in Pennsylvania Full story
5. FDA launches pilot to boost domestic drug manufacturing Full story
6. How are peers making purchasing calls ahead of 2026? Benchmark your strategy here.
7. Penn State sues insulin makers, PBMs over pricing scheme Full story
8. GLP-1 momentum drives 79% pharma M&A surge Full story
Becker's Learning Opportunities
9. New data: How value analysis and pharmacy leaders evaluate products now. Results here.
10. Nurse staffing ratios become a safety mandate in 2026. 3 strategic pillars to balance compliance and access here.
11. Patient experience starts with knowing 'who is who.' These 4 systems nailed it — see how here.
12. Interested in more? See Becker’s full lineup of
webinars and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
.png)
